A
APGE
Apogee Therapeutics Inc
86.27
-0.25-0.29%After Hours: 86.27 0.00 0.00%16:10 04/10 EDT
OPEN/PREV CLOSE86.53/86.52
TODAY RANGE85.47-88.35
VOL397.26K
MARKET CAP6.49B
52 WEEK RANGE26.20-88.35
AVG VOL (3M)1.04M
% TURNOVER0.53%
TURNOVER--
P/E (TTM)-20.4650
% RANGE3.07%
EPS(TTM)-4.2155
P/E(FORWARD)-18.8981
P/B6.53
BVPS13.21
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP6.00B
SHARES OUTSTANDING75.24M
NEXT EARNINGS05/11-05/15
FREE FLOAT69.59M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Reuters·04/04 00:01
Apogee CMO Carl Dambkowski disposes of USD 0.5 million common shares
Reuters·04/04 00:00
Apogee CFO Jane Henderson disposes of $0.2 million common shares
TipRanks·03/31 10:56
Guggenheim Keeps Their Buy Rating on Apogee Therapeutics (APGE)
NASDAQ·03/30 14:49
XBI, IBRX, TGTX, APGE: Large Outflows Detected at ETF
Dow Jones·03/30 14:07
Apogee Therapeutics Is Maintained at Outperform by Mizuho
Benzinga·03/30 13:57
Mizuho Maintains Outperform on Apogee Therapeutics, Raises Price Target to $110
TipRanks·03/30 11:27
Apogee Therapeutics price target raised to $110 from $105 at Mizuho
Same Industry
Name/Symbol
Change%
Price